VERASTEM, INC.
Profile
Company Names
VERASTEM, INC.
Addresses
117 KENDRICK STREET, SUITE 500, NEEDHAM, MA 02494
215 FIRST STREET, SUITE 440, CAMBRIDGE, MA 02142
Phone Numbers
(781) 292-4200
617-252-9300
Entity Type:
CORPORATION
Industry:
PHARMACEUTICALS, BIOTECHNOLOGY
Year Incorporated:
2010
State Incorporated:
DELAWARE
Total Amount Raised:
$163,180,560.00
Number of Funding Rounds:
6
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
6
2020-02-27
$100,000,000.00
$100,000,000.00
$0.00
Equity
5
2019-12-23
$4,829,628.00
$4,829,628.00
$0.00
Debt
4
2014-02-21
$3,898,326.00
$3,898,326.00
$0.00
Equity
3
2012-07-11
$2,000,000.00
$2,000,000.00
$0.00
Equity
2
2011-11-01
$20,402,606.00
$20,402,606.00
$0.00
Equity
1
2011-07-12
$32,050,000.00
$32,050,000.00
$0.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
RICHARD
ALDRICH
DIRECTOR
TIMOTHY
BARBERICH
DIRECTOR
PAUL
BRANNELLY
EXECUTIVE OFFICER
JOHN
K.
CLARKE
DIRECTOR
ROBERT
FORRESTER
EXECUTIVE OFFICER, DIRECTOR
ANSBERT
GADICKE
DIRECTOR
ELIXIR PHARMACEUTICALS, INC.
| CERIMON PHARMACEUTICALS, INC.
| MPM BIOVENTURES V, L.P.
| VERASTEM, INC.
| ONCOLOGY INVESTORS OF TEXAS COSTIM, LLC
| MITOKYNE, INC.
| CLINICAL INK, INC.
| VIRACYTE, INC.
| ALLOVIR, INC.
| MPM ONCOLOGY INNOVATIONS FUND LP
| ITEOS THERAPEUTICS, INC.
| ONCOLOGY IMPACT FUND 2, L.P.
| ORNA THERAPEUTICS HOLDINGS, LLC
| NEXTPOINT THERAPEUTICS, INC.
| MPM BIOVENTURES 2022, L.P.
| REUNION NEUROSCIENCE MANAGEMENT, INC.
| REUNION NEUROSCIENCE, INC.
JOHN
GREEN
EXECUTIVE OFFICER
CATCH THE WIND LTD.
| ICON CAPITAL CORP
| VERASTEM, INC.
| ODYSSEY MEDIA GROUP, INC.
| CIRKUL, INC.
| INNOVATIVE SOLAR VENTURES I LLC
| CITYFUNDS I, LLC - SERIES #AUSTIN
| CITYFUNDS I, LLC - SERIES #MIAMI
| CITYFUNDS I, LLC - SERIES #DALLAS
| NADA HOLDINGS, INC.
| BLACKSTAR STABILITY DISTRESSED DEBT FUND LLC
| CITYFUNDS PORTFOLIO FUND, LLC
| I-O UROLOGY CORP
| CITYFUNDS YIELD, LLC
| US HOME EQUITY FUND I, L.P.
PIYUSH
GUPTA
DIRECTOR
MICHAEL
KAUFFMAN
DIRECTOR
STEPHEN
KRAUS
DIRECTOR
ALISON
LAWTON
DIRECTOR
ERIC
ROWINSKY
DIRECTOR
HENRI
TERMEER
DIRECTOR
CHRISTOPH
WESTPHAL
EXECUTIVE OFFICER, DIRECTOR
VERASTEM, INC.
| OVASCIENCE, INC.
| FLEX PHARMA, INC.
| RECROS MEDICA, INC.
| PYXIS ONCOLOGY, INC.
| TSCAN THERAPEUTICS, INC.
| WEREWOLF THERAPEUTICS, INC.
| LONGWOOD FUND V, L.P.
| IMMUNEID, INC.
| IMMUNITAS THERAPEUTICS, INC.
| LONGWOOD FUND VI, L.P.
| LONGWOOD SPECIAL SITUATIONS FUND, L.P.
| NEWLEOS THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2020-02-27
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2019-12-23
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2014-02-21
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2012-07-11
D/A
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2011-11-01
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2011-11-01

